461 results on '"Severe fever with thrombocytopenia syndrome"'
Search Results
2. Clinical characteristics and influencing factors of severe fever with thrombocytopenia syndrome complicated by viral myocarditis: a retrospective study.
- Author
-
Du Q, Yu J, Chen Q, Chen X, Jiang Q, Deng L, Li A, and Xiong Y
- Subjects
- Humans, Retrospective Studies, Consciousness Disorders complications, Fever complications, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia complications, Thrombocytopenia diagnosis, Myocarditis complications, Myocarditis diagnosis, Virus Diseases, Phlebovirus
- Abstract
Objective: This study aimed to investigate the clinical characteristics of severe fever with thrombocytopenia syndrome complicated by viral myocarditis (SFTS-VM) and analyze relevant influencing factors., Methods: Retrospective analysis was conducted on clinical data from 79 SFTS-VM patients, categorized into common (SFTS-CVM, n = 40) and severe groups (SFTS-SVM, n = 39). Clinical manifestations, laboratory results, cardiac ultrasonography, and electrocardiogram features were analyzed. Univariate and multivariate analyses identified significant indicators, which were further assessed using ROC curves to predict SFTS-SVM., Results: SFTS-SVM group exhibited higher rates of hypotension, shock, abdominal pain, cough with sputum, and consciousness disorders compared to SFTS-CVM group. Laboratory findings showed elevated platelet count, ALT, AST, amylase, lipase, LDH, D-dimer, procalcitonin, TNI, and NT-proBNP in SFTS-SVM. Abnormal electrocardiograms, especially atrial fibrillation, were more prevalent in SFTS-SVM (P < 0.05). Multivariate analysis identified elevated LDH upon admission (OR = 1.004, 95% CI: 1-1.008, P = 0.050), elevated NT-proBNP (OR = 1.005, 95% CI: 1.001-1.008, P = 0.007), and consciousness disorders (OR = 112.852, 95% CI: 3.676 ~ 3464.292, P = 0.007) as independent risk factors for SFTS-SVM. LDH and NT-proBNP had AUCs of 0.728 and 0.744, respectively, in predicting SFTS-SVM. Critical values of LDH (> 978.5U/L) and NT-proBNP (> 857.5pg/ml)) indicated increased likelihood of SFTS progression into SVM., Conclusion: Elevated LDH, NT-proBNP, and consciousness disorders independently correlate with SFTS-SVM. LDH and NT-proBNP can aid in early identification of SFTS-SVM development when above specified thresholds., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
3. Systemic inflammatory response syndrome in patients with severe fever with thrombocytopenia syndrome: prevalence, characteristics, and impact on prognosis.
- Author
-
Zhang Z, Hu X, Jiang Q, Jiao F, Du Q, Liu J, Luo M, Li A, Deng L, and Xiong Y
- Subjects
- Humans, Retrospective Studies, Prevalence, Fever epidemiology, Prognosis, Systemic Inflammatory Response Syndrome epidemiology, Systemic Inflammatory Response Syndrome complications, China epidemiology, Severe Fever with Thrombocytopenia Syndrome, Phlebovirus, Thrombocytopenia complications
- Abstract
Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging zoonosis with a high fatality rate in China. Previous studies have reported that dysregulated inflammatory response is associated with disease pathogenesis and mortality in patients with SFTS. This investigation aimed to evaluate the prevalence and characteristics of systemic inflammatory response syndrome (SIRS), and its impact on prognosis., Methods: Data on demographic characteristics, comorbid conditions, clinical manifestations, laboratory parameters, and survival time of patients with SFTS were collected. Patients were divided into the non-SIRS and SIRS groups according to the presence of SIRS, then their clinical data were compared., Results: A total of 290 patients diagnosed with SFTS were retrospectively enrolled, including 126(43.4%) patients with SIRS. Patients in the non-survivor group had more prevalence of SIRS than patients in the survivor group (P < 0.001), and SIRS (adjusted OR 2.885, 95% CI 1.226-6.786; P = 0.005) was shown as an independent risk factor for prognosis of patients with SFTS. Compared with patients without SIRS, patients with SIRS had lower WBC and neutrophils counts, and fibrinogen levels, but higher AST, LDH, amylase, lipase, CK, CK-MB, troponin I, APTT, thrombin time, D-dimer, CRP, IL-6, SAA levels, and viral load. The cumulative survival rate of patients with SIRS was significantly lower than that of patients without SIRS. Patients with SIRS also showed a higher incidence of bacterial or fungal infections than patients without SIRS., Conclusions: SIRS is highly frequent in patients with SFTS, and it is associated with high mortality., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
4. [Epidemiological characteristics of severe fever with thrombocytopenia syndrome in China, 2018-2021].
- Author
-
Huang XX, Du SS, Li AQ, Li C, Tian TT, Liu TZ, Wang Q, Liang MF, Wang SW, Li JD, and Li DX
- Subjects
- Middle Aged, Humans, Female, Male, Fever epidemiology, China epidemiology, Incidence, Severe Fever with Thrombocytopenia Syndrome, Phlebovirus, Thrombocytopenia epidemiology, Bunyaviridae Infections epidemiology
- Abstract
Objective: To understand the epidemiological characteristics and incidence trend of severe fever with thrombocytopenia syndrome (SFTS) in China. Methods: The incidence data of SFTS in China from 2018 to 2021 were collected from Chinese Disease Prevention and Control Information System for a statistical and descriptive epidemiological analysis by using software such as Excel 2016, Joinpoint 5.0.2, SPSS 26.0, and GraphPad Prism 8.0, especially, the SFTS cases reported monthly by key provinces were analyzed. Results: From 2018 to 2021, a total of 8 835 SFTS cases were reported in 25 provinces and the annual incidence showed an upward trend. The distribution of SFTS cases showed clustering, but the cases were mainly sporadic ones. The cases began to increase in March, mainly occurred during April to October (96.79%,8 551/8 835), and peaked during May to July. The cases were mainly distributed in middle-aged and old farmers, and slight more cases were women. The average case fatality rate was 5.38%, which varied greatly with areas. The case fatality rate tended to increase with age. Conclusion: From 2018 to 2021, the epidemiological characteristics of SFTS in China remained stable, but the number of reported cases gradually increased and the distribution showed an expanding trend, to which close attention should be paid.
- Published
- 2024
- Full Text
- View/download PDF
5. Spatiotemporal distribution and environmental influences of severe fever with thrombocytopenia syndrome in Shandong Province, China.
- Author
-
Duan Q, Tian X, Pang B, Zhang Y, Xiao C, Yao M, Ding S, Zhang X, Jiang X, and Kou Z
- Subjects
- Animals, Cattle, Incidence, China epidemiology, Severe Fever with Thrombocytopenia Syndrome, Phlebovirus, Thrombocytopenia epidemiology
- Abstract
Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease discovered in China in 2009. The purpose of this study was to describe the spatiotemporal distribution of SFTS and to identify its environmental influencing factors and potential high-risk areas in Shandong Province, China., Methods: Data on the SFTS incidence from 2010 to 2021 were collected. Spatiotemporal scan statistics were used to identify the time and area of SFTS clustering. The maximum entropy (MaxEnt) model was used to analyse environmental influences and predict high-risk areas., Results: From 2010 to 2021, a total of 5705 cases of SFTS were reported in Shandong. The number of SFTS cases increased yearly, with a peak incidence from April to October each year. Spatiotemporal scan statistics showed the existence of one most likely cluster and two secondary likely clusters in Shandong. The most likely cluster was in the eastern region, from May to October 2021. The first secondary cluster was in the central region, from May to October 2021. The second secondary cluster was in the southeastern region, from May to September 2020. The MaxEnt model showed that the mean annual wind speed, NDVI, cattle density and annual cumulative precipitation were the key factors influencing the occurrence of SFTS. The predicted risk map showed that the area of high prevalence was 28,120 km
2 , accounting for 18.05% of the total area of the province., Conclusions: The spatiotemporal distribution of SFTS was heterogeneous and influenced by multidimensional environmental factors. This should be considered as a basis for delineating SFTS risk areas and developing SFTS prevention and control measures., (© 2023. The Author(s).)- Published
- 2023
- Full Text
- View/download PDF
6. The pathogenic and clinical characteristics of severe fever with thrombocytopenia syndrome patients with co-infections.
- Author
-
Song H, Zou S, Huang Y, Wang Y, Wang T, Wei W, Sun Z, and Hou H
- Subjects
- Humans, Retrospective Studies, Severe Fever with Thrombocytopenia Syndrome, Coinfection, Phlebovirus, Bunyaviridae Infections complications, Bunyaviridae Infections diagnosis, Bunyaviridae Infections epidemiology, Thrombocytopenia complications, Thrombocytopenia diagnosis
- Abstract
Objective: The study aimed to comprehensively describe and evaluate the pathogenic and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) patients with co-infections., Methods: We retrospectively collected clinical data and laboratory indicators of the SFTS patients at Tongji Hospital from October 2021 to July 2023., Results: A total of 157 patients with SFTS virus (SFTSV) infection were involved in the analysis, including 43 co-infection and 114 non-co-infection patients. The pathogens responsible for co-infection were primarily isolated from respiratory specimens. Fungal infections, primarily Aspergillus fumigatus , were observed in 22 cases. Bacterial infections, with Klebsiella pneumoniae and carbapenem-resistant Acinetobacter baumannii as the main pathogens, were identified in 20 cases. SFTS patients with co-infection exhibited higher mortality ( P =0.011) compared to non-co-infection patients. Among SFTS patients co-infected with both bacteria and fungi (8 cases) or specific drug-resistant strains (11 cases), the mortality rate was as high as 70% (14/19). In comparison with the non-co-infection group, SFTS patients with co-infection displayed significant alteration in inflammatory markers, coagulation function, and liver function indicators., Conclusion: The mortality rate of SFTS patients with co-infection is relatively high, underscoring the need for enhanced monitoring and timely, appropriate treatment to minimize the mortality rate., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Song, Zou, Huang, Wang, Wang, Wei, Sun and Hou.)
- Published
- 2023
- Full Text
- View/download PDF
7. Clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) sepsis and non-SFTS sepsis.
- Author
-
Xu Y, Yang X, Qu C, and Jia J
- Subjects
- Humans, Retrospective Studies, Fever, Severe Fever with Thrombocytopenia Syndrome, Phlebovirus physiology, Thrombocytopenia, Sepsis
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is a new infectious disease caused by bunyavirus, and the critically cases conform to the definition of sepsis. In order to compare the differences between SFTS sepsis and non-SFTS sepsis, a retrospective analysis was performed. Thirty-seven SFTS sepsis and 96 non-SFTS sepsis patients were enrolled. The clinical characteristics, laboratory results were compared between the two groups and independent prognostic risk of mortality were investigated respectively. Compared with non-SFTS sepsis, SFTS cases had lower white blood cell, neutrophil and platelet counts, prolonged activated partial thromboplastin time and decreased fibrinogen, slightly elevated inflammatory indicators. Interleukin-6 (IL-6), and acute physiology and chronic health evaluation Ⅱ (APACHE II) score were independent prognostic risk factors in non-SFTS sepsis. The mortality risk of STFS sepsis was related to the viral clearance. There was no difference in viral load between SFTS survivors and non-survivors on admission. However, the differences were significant on 5th, 7th, 10th, and 14th day, and all SFTS non-survivors died within 14 days. Viral clearance rate on 7th day was an independent risk factor for mortality in SFTS sepsis. The mortality risk of STFS sepsis was related to the viral clearance rate., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interest., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
8. A case of neutrophil blue-green inclusions in severe fever with thrombocytopenia syndrome virus infection.
- Author
-
Jiang W, Huang M, Chen JH, Fei Y, and Zhang C
- Subjects
- Humans, Neutrophils, Severe Fever with Thrombocytopenia Syndrome, Phlebovirus, Thrombocytopenia
- Published
- 2023
- Full Text
- View/download PDF
9. Severe fever with thrombocytopenia syndrome virus induces platelet activation and apoptosis via a reactive oxygen species-dependent pathway.
- Author
-
Li YH, Wang XH, Huang WW, Tian RR, Pang W, and Zheng YT
- Subjects
- Humans, Animals, Mice, Reactive Oxygen Species, Antioxidants, Glycoproteins metabolism, Platelet Activation, Severe Fever with Thrombocytopenia Syndrome, Bunyaviridae Infections metabolism, Thrombocytopenia metabolism
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne infectious disease caused by the SFTS virus (SFTSV) and with a high fatality rate. Thrombocytopenia is a major clinical manifestation observed in SFTS patients, but the underlying mechanism remains largely unclear. Here, we explored the effects of SFTSV infection on platelet function in vivo in severely infected SFTSV IFNar
-/- mice and on mouse and human platelet function in vitro. Results showed that SFTSV-induced platelet clearance acceleration may be the main reason for thrombocytopenia. SFTSV-potentiated platelet activation and apoptosis were also observed in infected mice. Further investigation showed that SFTSV infection induced platelet reactive oxygen species (ROS) production and mitochondrial dysfunction. In vitro experiments revealed that administration of SFTSV or SFTSV glycoprotein (Gn) increased activation, apoptosis, ROS production, and mitochondrial dysfunction in separated mouse platelets, which could be effectively ameliorated by the application of antioxidants (NAC (N-acetyl-l-cysteine), SKQ1 (10-(6'-plastoquinonyl) decyltriphenylphosphonium) and resveratrol). In vivo experiments showed that the antioxidants partially rescued SFTSV infection-induced thrombocytopenia by improving excessive ROS production and mitochondrial dysfunction and down-regulating platelet apoptosis and activation. Furthermore, while SFTSV and Gn directly potentiated human platelet activation, it was completely abolished by antioxidants. This study revealed that SFTSV and Gn can directly trigger platelet activation and apoptosis in an ROS-MAPK-dependent manner, which may contribute to thrombocytopenia and hemorrhage during infection, but can be abolished by antioxidants., Competing Interests: Declaration of competing interest All authors declare that there are no conflicts of interest., (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
10. Successful Recovery from Severe Fever with Thrombocytopenia Syndrome and Hemophagocytic Lymphohistiocytosis with Standard Treatment and a Calcium Channel Blocker of Nicardipine Hydrochloride.
- Author
-
Yamauchi N, Hongo T, Kawakami M, Inoguchi K, Oguni S, Momoki N, Ueno A, Ikeda F, Fujioka S, and Yamamoto K
- Subjects
- Male, Humans, Aged, Calcium Channel Blockers therapeutic use, Nicardipine, Ferritins, Severe Fever with Thrombocytopenia Syndrome complications, Phlebovirus, Lymphohistiocytosis, Hemophagocytic complications, Lymphohistiocytosis, Hemophagocytic drug therapy, Lymphohistiocytosis, Hemophagocytic diagnosis, Thrombocytopenia complications, Thrombocytopenia drug therapy
- Abstract
A 67-year-old man was admitted to our hospital with a high fever. Laboratory tests revealed leukopenia, thrombocytopenia, liver dysfunction, rhabdomyolysis, and hyperferritinemia. He was diagnosed with severe fever with thrombocytopenia syndrome (SFTS) complicated by hemophagocytic lymphohistiocytosis and treated with steroid therapy, intravenous calcium channel blocker (CCB), and supportive care, without favipiravir. Serum levels of ferritin and soluble interleukin 2 receptor (sIL2R) were markedly elevated on Day 3 after admission and decreased thereafter, while an SFTS viral load of 6.8×10
4 copies/μL was detected on Day 2, increasing to 2.9×105 copies/μL on Day 6. Serum ferritin and sIL2R levels may be better indicators of mortality than the SFTS viral load, and CCBs may have a therapeutic effect.- Published
- 2023
- Full Text
- View/download PDF
11. Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study.
- Author
-
Zuo Y, Wang H, Huang J, Zhang F, Lv D, Meng T, Bibi A, Shen J, Wang L, Wang Z, and Xu Y
- Subjects
- Adult, Humans, Male, Aged, Female, Lung, Severe Fever with Thrombocytopenia Syndrome, Phlebovirus, Thrombocytopenia complications, Thrombocytopenia epidemiology, Pneumonia complications
- Abstract
Co-infection in patients with severe fever with thrombocytopenia syndrome (SFTS) has been reported, posing a serious threat to survival and treatment. We aimed to systematically investigate the SFTS associated pulmonary infection, particularly invasive pulmonary fungal infection (IPFI). During April 2019 to October 2021, we conducted a multicentre observational study on adult hospitalized patients confirmed with SFTS from three tertiary hospital in central China. Demographic, clinical and laboratory data of patients were collected and re-assessed. A total of 443 patients (51.7% were male sex) were included for analysis with median age of 65-year-old. Among them, 190 (42.9%) patients met the criteria for pulmonary infection. Pulmonary infection was associated with shorter survival time (p < 0.0001 by log-rank test), and adjusted hazard ratio was 1.729 [95% confidence interval, 1.076-2.780] (p = 0.024). Age (odds ratio (OR) 1.040 [1.019-1.062], p < 0.001), time from onset to admission (OR 1.163 [1.070-1.264], p < 0.001), having severe status (OR 3.166 [2.020-4.962], p < 0.001) and symptoms of skin change (OR 2.361 [1.049-5.316], p < 0.001) at admission and receiving intravenous immunoglobin (OR 2.185 [1.337-3.569], p = 0.002) were independent risk factors for the occurrence of pulmonary infection. A total of 70 (15.8%) patients were defined as IPFI. Multivariate analysis showed that time from onset to admission (OR 1.117 [1.016-1.229], p = 0.022), severe status (OR 5.737 [3.054-10.779], p < 0.001), having smoking history (OR 3.178 [1.251-8.070], p = 0.015) and autoimmunity disease (OR 7.855 [1.632-37.796], p = 0.010), receiving intravenous immunoglobin (OR 3.270 [1.424-7.508], p = 0.005) were independent risk factors for the occurrence of IPFI. In SFTS patients with pulmonary infection, white blood count <2.09 × 10
9 per L (OR 11.064 [3.708-33.012], p < 0.001) and CD3+ CD4+ T cell count <104.0 per μL (OR 10.429 [3.395-32.038], p < 0.001) could independently predict IPFI. This study showed the high prevalence and poor outcomes of pulmonary infection and IPFI in patients with SFTS. These findings highlighted the need for active surveillance of fungal pathogens and early antifungal treatment in patients with SFTS., (© 2023 Wiley Periodicals LLC.)- Published
- 2023
- Full Text
- View/download PDF
12. A new model for predicting the outcome and effectiveness of drug therapy in patients with severe fever with thrombocytopenia syndrome: A multicenter Chinese study.
- Author
-
Xia G, Sun S, Zhou S, Li L, Li X, Zou G, Huang C, Li J, and Zhang Z
- Subjects
- Humans, Ribavirin therapeutic use, Retrospective Studies, C-Reactive Protein, Severe Fever with Thrombocytopenia Syndrome, Phlebovirus, Thrombocytopenia
- Abstract
Background: There are a few models for predicting the outcomes of patients with severe fever with thrombocytopenia syndrome (SFTS) based on single-center data, but clinicians need more reliable models based on multicenter data to predict the clinical outcomes and effectiveness of drug therapy., Methodology/principal Findings: This retrospective multicenter study analyzed data from 377 patients with SFTS, including a modeling group and a validation group. In the modeling group, the presence of neurologic symptoms was a strong predictor of mortality (odds ratio: 168). Based on neurologic symptoms and the joint indices score, which included age, gastrointestinal bleeding, and the SFTS virus viral load, patients were divided into double-positive, single-positive, and double-negative groups, which had mortality rates of 79.3%, 6.8%, and 0%, respectively. Validation using data on 216 cases from two other hospitals yielded similar results. A subgroup analysis revealed that ribavirin had a significant effect on mortality in the single-positive group (P = 0.006), but not in the double-positive or double-negative group. In the single-positive group, prompt antibiotic use was associated with reduced mortality (7.2% vs 47.4%, P < 0.001), even in individuals without significant granulocytopenia and infection, and early prophylaxis was associated with reduced mortality (9.0% vs. 22.8%, P = 0.008). The infected group included SFTS patients with pneumonia or sepsis, while the noninfected group included patients with no signs of infection. The white blood cell count and levels of C-reactive protein and procalcitonin differed significantly between the infection and non-infection groups (P = 0.020, P = 0.011, and P = 0.003, respectively), although the absolute difference in the medians were small., Conclusions/significance: We developed a simple model to predict mortality in patients with SFTS. Our model may help to evaluate the effectiveness of drugs in these patients. In patients with severe SFTS, ribavirin and antibiotics may reduce mortality., Competing Interests: None, (Copyright: © 2023 Xia et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
13. Sex differences in incidence and fatality of severe fever with thrombocytopenia syndrome: A comparative study based on national surveillance data of China.
- Author
-
Qian J, Wei J, Ren L, Liu Y, and Feng L
- Subjects
- Humans, Male, Female, Incidence, Sex Characteristics, Fever epidemiology, China epidemiology, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia epidemiology, Thrombocytopenia diagnosis, Phlebovirus, Bunyaviridae Infections epidemiology
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne emerging infectious disease with an increasingly global concern. Sex difference in infectious diseases is an important public health problem. A comparative study on sex differences in SFTS incidence and fatality was conducted using all laboratory-confirmed cases in mainland China during 2010-2018. Females had significantly higher average annual incidence rate (AAIR) with a risk ratio (RR) of 1.17 (95% confidence interval [CI] 1.11-1.22; p ˂ 0.0001), but significantly lower-case fatality rate (CFR) with an odd ratio of 0.73 (95% CI 0.61-0.87; p = 0.001). The significant differences in AAIR and CFR were observed in age groups of 40-69 and 60-69 years, respectively (both p < 0.05). There was a rising incidence and declining CFR along with epidemic years. After adjusting for age, temporal and spatial distribution, agricultural setting and onset-to-diagnosis interval, the female-to-male difference in either AAIR or CFR remained significant. The underlying biological mechanisms of the sex-based differences that the females are more prone to get the disease, but less likely for a fatal outcome deserve further investigations., (© 2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
14. The clinical and immunological characteristics in fatal severe fever with thrombocytopenia syndrome virus (SFTSV) infection.
- Author
-
Huang M, Wang T, Huang Y, Wang Y, Wu S, Wang F, Tang G, Wei W, Liu W, and Hou H
- Subjects
- Humans, Lymphocyte Subsets pathology, Prognosis, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia, Phlebovirus
- Abstract
Objective: This study aimed to make a comprehensive evaluation of peripheral immune profiles for further understanding the immunopathogenesis of severe fever with thrombocytopenia syndrome (SFTS)., Methods: Forty-seven patients with SFTS virus infection were included, of which 24 were deceased. The percentages, absolute numbers, phenotype of lymphocyte subsets were detected by flow cytometry., Results: In patients with SFTS, the numbers of CD3
+ T, CD4+ T, CD8+ T and NKT cells were decreased compared with healthy controls (HCs), accompanied with highly active and exhausted phenotypes for T cells, and overproliferating plasmablasts. High inflammatory status, dysregulation of coagulation and host immune response were more obvious in deceased patients than that of survivors. Higher levels of PCT, IL-6, IL-10, TNF-α, APTT, TT and the occurrence of hemophagocytic lymphohistiocytosis were poor prognostic indicators of SFTS., Conclusions: The evaluation of immunological markers in combination with laboratory tests has critical value for selecting prognostic markers and potential treatment target., Competing Interests: Declaration of Competing Interest The authors declare that they have no competing interests., (Copyright © 2023. Published by Elsevier Inc.)- Published
- 2023
- Full Text
- View/download PDF
15. Increased Risk of Infection with Severe Fever with Thrombocytopenia Virus among Animal Populations on Tsushima Island, Japan, Including an Endangered Species, Tsushima Leopard Cats.
- Author
-
Matsuu A, Doi K, Ishijima K, Tatemoto K, Koshida Y, Yoshida A, Kiname K, Iwashita A, Hayama SI, and Maeda K
- Subjects
- Humans, Animals, Cats, Dogs, Endangered Species, Japan epidemiology, Seroepidemiologic Studies, Deer, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Panthera, Thrombocytopenia, Bunyaviridae Infections epidemiology, Bunyaviridae Infections veterinary
- Abstract
To investigate the seroprevalence of severe fever with thrombocytopenia syndrome (SFTS) among wild and companion animals on Tsushima Island, Japan, SFTS virus (SFTSV)-specific ELISA and virus-neutralizing tests were conducted on 50 wild boars, 71 Sika deer, 84 dogs, 323 domestic cats, and 6 Tsushima leopard cats. In total, 1 wild boar (1.8%), 2 dogs (2.4%), 7 domestic cats (2.2%), and 1 Tsushima leopard cat (16.7%) were positive for anti-SFTSV antibodies. Among the 11 positive animals, 10 were collected after 2019, and all were found on the southern part of the island. SFTSV, thus far, seems to be circulating within a limited area of Tsushima Island. To protect humans and animals, including endangered Tsushima leopard cats, from SFTSV infection, countermeasures are needed to prevent the spread of SFTSV on Tsushima Island.
- Published
- 2022
- Full Text
- View/download PDF
16. Confirmed cases of severe fever with thrombocytopenia syndrome in companion cats with a history of tick exposure in the Republic of Korea.
- Author
-
Han SW, An JH, Rim JM, Jeong E, Noh S, Kang M, Kang JG, and Chae JS
- Subjects
- Cats, Animals, Pets, Republic of Korea epidemiology, Severe Fever with Thrombocytopenia Syndrome diagnosis, Severe Fever with Thrombocytopenia Syndrome epidemiology, Severe Fever with Thrombocytopenia Syndrome veterinary, Bunyaviridae Infections diagnosis, Bunyaviridae Infections epidemiology, Bunyaviridae Infections veterinary, Phlebovirus genetics, Tick-Borne Diseases diagnosis, Tick-Borne Diseases epidemiology, Tick-Borne Diseases veterinary, Thrombocytopenia veterinary, Ticks, Cat Diseases diagnosis, Cat Diseases epidemiology
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is a zoonotic disease, and its clinical information and prevalence are important. This study was conducted on 22 feline patients from the Republic of Korea (ROK), suspected to suffer from a tick-borne disease. Four cats were positive for SFTS, and genotypes B-1, B-3, D, and F were identified. Clinical symptoms, such as anorexia, jaundice, thrombocytopenia, leukopenia, and hyperbilirubinemia, were detected. This is the first report of SFTS virus genotypes B-1, D, and F from cats in the ROK. Moreover, our results suggest that jaundice may be an indicator of SFTS in cats., Competing Interests: The authors declare no conflicts of interest., (© 2022 The Korean Society of Veterinary Science.)
- Published
- 2022
- Full Text
- View/download PDF
17. Analysis of Clinical Characteristics and Laboratory Data Related to the Prognosis of Korean Severe Fever with Thrombocytopenia Syndrome Patients: A Single-Center Study.
- Author
-
Kim M, Hong KW, Kim SC, Kim RB, and Cho MC
- Subjects
- Animals, Phlebovirus, Prognosis, Retrospective Studies, Republic of Korea, Severe Fever with Thrombocytopenia Syndrome diagnosis, Severe Fever with Thrombocytopenia Syndrome pathology, Thrombocytopenia diagnosis, Thrombocytopenia pathology
- Abstract
Background: Severe fever with thrombocytopenia syndrome (SFTS), an emerging viral infectious disease, is mainly transmitted by ticks in the surrounding environment. Clinical progress and risk factors for prognosis in SFTS patients were not yet fully understood. Thus, the objective of this study was to analyze clinical progression and laboratory data related to the prognosis of South Korean SFTS patients in a single institution from 2014 to 2021. Materials and Methods: Fifty-three confirmed SFTS patients from August 2014 to September 2021 at Gyeongsang National University Hospital (GNUH) in Jinju, South Korea were enrolled. Electronic medical records of SFTS patients' demographic features, clinical data, and laboratory data were retrospectively reviewed. Risk factors for fatality were statistically analyzed by classifying enrolled patients into fatal and non-fatal groups. Results: The mean age of patients in the fatal group was significantly higher than that in the non-fatal group ( p = 0.036). Hemorrhagic manifestations ( p = 0.001) and multiple organ dysfunction (MOD) ( p < 0.001) were significantly common in the fatal group. Age, hemorrhagic manifestations, and MOD were also associated with death ( p = 0.001, p = 0.008, and p = 0.041, respectively), with adjusted hazard ratios (aHRs) of 1.14, 18.25, and 2.36, respectively. Onset of illness to admission was also significantly associated with death ( p = 0.005), with aHR of 0.48. Age, interval from onset of illness to admission, hemorrhagic manifestations, and MOD were found to be variables related to the fatality of SFTS patients. Conclusion: Laboratory test results showed a significant difference between the fatal group and the non-fatal group, but they did not have a statistically significant effect on the prognosis of SFTS patients.
- Published
- 2022
- Full Text
- View/download PDF
18. [Severe Fever With Thrombocytopenia Syndrome and Associated Encephalopathy].
- Author
-
Takahashi T
- Subjects
- Humans, Brain Diseases complications, Bunyaviridae Infections complications, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia complications
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne viral hemorrhagic fever caused by the SFTS virus (SFTSV). Approximately 80 patients are infected annually, mainly in western Japan, and the case fatality rate is >20%. The clinical presentation of SFTS typically includes fever, thrombocytopenia, leukocytopenia, and gastrointestinal symptoms. Localized lymphadenopathy, coagulopathy associated with prolonged activated partial thromboplastin time, muscular symptoms, and neurological abnormalities referred to as SFTS encephalopathy are often observed. Besides tick-borne spread, SFTSV infection is increasingly being transmitted via SFTS-infected cats. Clinicians should remain mindful of this emerging viral infection.
- Published
- 2022
- Full Text
- View/download PDF
19. Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review).
- Author
-
Yang T, Huang H, Jiang L, and Li J
- Subjects
- Humans, Bunyaviridae Infections drug therapy, Bunyaviridae Infections pathology, Phlebovirus physiology, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia pathology
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) has been acknowledged as an emerging infectious disease that is caused by the SFTS virus (SFTSV). The main clinical features of SFTS on presentation include fever, thrombocytopenia, leukocytopenia and gastrointestinal symptoms. The mortality rate is estimated to range between 5‑30% in East Asia. However, SFTSV infection is increasing on an annual basis globally and is becoming a public health problem. The transmission cycle of SFTSV remains poorly understood, which is compounded by the pathogenesis of SFTS not being fully elucidated. Since the mechanism underlying the host immune response towards SFTSV is also unclear, there are no effective vaccines or specific therapeutic agents against SFTS, with supportive care being the only realistic option. Therefore, it is now crucial to understand all aspects of the host‑virus interaction following SFTSV infection, including the antiviral states and viral evasion mechanisms. In the present review, recent research progress into the possible host immune responses against SFTSV was summarized, which may be useful in designing novel therapeutics against SFTS.
- Published
- 2022
- Full Text
- View/download PDF
20. Tocilizumab therapy for IL-6 increment in a patient with non-fatal severe fever with thrombocytopenia syndrome.
- Author
-
Yoo JR, Lee KH, Kim M, Oh HJ, and Heo ST
- Subjects
- Fever drug therapy, Humans, Interleukin-6, Bunyaviridae Infections, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia drug therapy
- Abstract
We report the administration of an anti-interleukin (IL)-6 antibody in a case of severe fever with thrombocytopenia syndrome (SFTS) with an increase in IL-6. On the day of admission, SFTS viral load and IL-6 concentration were 93 831 copies/ml and 5.4 pg/ml, respectively, and tocilizumab was administered. SFTS viral load decreased to 17 821.1 copies/ml on the 3
rd day of admission, while IL-6 levels increased to 104.9 pg/ml; SFTS viral load and IL-6 levels had decreased to 2876.4 copies/ml and 48.2 pg/ml on 7th day of admission, respectively. The patient fully recovered no tocilizumab adverse events., Competing Interests: Conflict of Interest None of the authors have any conflicts of interest to declare in relation to this work., (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
21. The role of selenium in severe fever with thrombocytopenia syndrome: an integrative analysis of surveillance data and clinical data.
- Author
-
Che TL, Li XL, Tian JB, Wang G, Peng XF, Zhang HY, Chen JH, Zhu Y, Zhang WH, Wang T, Liu BC, Xu Q, Lv CL, Jiang BG, Li ZJ, Fang LQ, and Liu W
- Subjects
- China epidemiology, Fever epidemiology, Humans, Bunyaviridae Infections, Phlebovirus, Selenium, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia epidemiology
- Abstract
Objectives: Selenium deficiency can be associated with increased susceptibility to some viral infections and even more severe diseases. In this study, we aimed to examine whether this association applies to severe fever with thrombocytopenia syndrome (SFTS)., Method: An observational study was conducted based on the data of 13,305 human SFTS cases reported in mainland China from 2010 to 2020. The associations among incidence, case fatality rate of SFTS, and crop selenium concentration at the county level were explored. The selenium level in a cohort of patients with SFTS was tested, and its relationship with clinical outcomes was evaluated., Results: The association between selenium-deficient crops and the incidence rate of SFTS was confirmed by multivariate Poisson analysis, with an estimated incidence rate ratio (IRR, 95% confidence interval [CI]) of 4.549 (4.215-4.916) for moderate selenium-deficient counties and 16.002 (14.706-17.431) for severe selenium-deficient counties. In addition, a higher mortality rate was also observed in severe selenium-deficient counties with an IRR of 1.409 (95% CI: 1.061-1.909). A clinical study on 120 patients with SFTS showed an association between serum selenium deficiency and severe SFTS (odds ratio, OR: 2.94; 95% CI: 1.00-8.67) or fatal SFTS (OR: 7.55; 95% CI: 1.14-50.16)., Conclusion: Selenium deficiency is associated with increased susceptibility to SFTS and poor clinical outcomes., Competing Interests: Conflict of interest The authors have no competing interests to declare., (Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
22. Effects of corticosteroid treatment in patients with severe fever with thrombocytopenia syndrome: A single-center retrospective cohort study.
- Author
-
Xiong L, Xu L, Lv X, and Zheng X
- Subjects
- Adrenal Cortex Hormones adverse effects, Cohort Studies, Fever, Humans, Retrospective Studies, Coinfection complications, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia drug therapy
- Abstract
Objectives: To evaluate the effect and safety of corticosteroid (CS) treatment in patients with severe fever with thrombocytopenia syndrome (SFTS)., Methods: Patients with and without CS were retrospectively compared by Cox regression and 1:1 propensity score matching analysis to evaluate the effects of CS on mortality and secondary infections in patients with SFTS., Results: A total of 467 patients with SFTS were enrolled in the cohort study, there were 52 fatal cases and 415 nonfatal cases, the overall fatality rate was 11.1%. The mortality was observed in 36/144 (25%) and 16/323 (5%) patients in the CS-treated and non-CS-treated groups, respectively (P < 0.001). Multi variate Cox regression analysis showed that the difference was not statistically significant for CS treatment in fatality (P > 0.05, aHR 0.767, 95% CI 0.360-1.634). Difference in survival time between the CS-treated and non-CS-treated groups after propensity score matching had no statistical significance (Log-rank test P = 0.390), whereas there was a significant difference in secondary infections between the CS-treated and non-CS-treated groups (P = 0.007)., Conclusion: Although the CS treatment had no impact on fatality in patients with SFTS, it increased the risk of secondary infections. Administration of CS in patients with SFTS should be carefully considered and evaluated the balance between therapeutic efficacy and adverse effects., (Copyright © 2022. Published by Elsevier Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
23. Severe fever with thrombocytopenia syndrome virus replicates in brain tissues and damages neurons in newborn mice.
- Author
-
Chen R, Li Q, Chen H, Yang H, Wei X, Chen M, and Wen H
- Subjects
- Animals, Animals, Newborn, Brain, Mice, Neurons, Bunyaviridae Infections epidemiology, Encephalitis, Phlebovirus physiology, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia epidemiology
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) virus (SFTSV) is an emerging tick-borne phlebovirus with a high fatality rate of 12-30%, which has an expanding endemic and caused thousands of infections every year. Central nervous system (CNS) manifestations are an important risk factor of SFTS outcome death. Further understanding of the process of how SFTSV invades the brain is critical for developing effective anti-SFTS encephalitis therapeutics. We obeserved changes of viral load in the brain at different time points after intraperitoneal infection of SFTSV in newborn C57/BL6 mice. The virus invaded the brain at 3 h post-infection (hpi). Notably, the viral load increased exponentially after 24 hpi. In addition, it was found that in addition to macrophages, SFTSV infected neurons and replicated in the brain. These findings provide insights into the CNS manifestations of severe SFTS, which may lead to drug development and encephalitis therapeutics., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
24. Clinical symptoms associated with fatality of severe fever with thrombocytopenia syndrome: A systematic review and meta-analysis.
- Author
-
Wang Y, Song Z, Xu X, Wei X, Yuan H, Liang H, and Wen H
- Subjects
- China epidemiology, Fever, Humans, Communicable Diseases, Emerging, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infection disease that is deadly if left untreated. Identification of potential risk factors with prognosis value may help to focus clinical management and reduce case fatality. However, information about these factors is conflicting and scattered. In this study, documents on SFTS were collected by searching PubMed, Web of Science, Chinese National Knowledge Infrastructure (CNKI) and Chinese Wan Fang Database through 12 January 2021. Meta-analysis was performed by using Stata and Review Manage software. 29 studies were included, involving 3011 participants with 38 clinical symptoms. The following factors were strongly (OR>5) and significantly (P-value<0.05) associated with mortality: hematemesis (OR=13.73), slurred speech (OR=5.05), disturbance of consciousness (OR=9.20), coma (OR=47.84), disseminated intravascular coagulation (OR=11.79), multiple organ dysfunction (OR=21.30), shock (OR=8.20) and acute kidney injury (OR=6.22). Non-specific symptoms, underlying diseases, respiratory symptoms and gastrointestinal symptoms were not associated with mortality of SFTS patients. Neurological symptoms and severe complications significantly increasing the death risk of SFTS cases can be identified by medical staff in resource-constrained settings and should be considered as core factors in future researchers that aim at improving the prognosis of SFTS patients., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
25. Scoring Model for Predicting the Occurrence of Severe Illness in Hospitalized Patients with Severe Fever with Thrombocytopenia Syndrome.
- Author
-
Wei X, Tu L, Qiu L, Chen M, Wang Y, Du M, Kan H, Dong Q, Xu X, Yuan H, Zhao L, and Wen H
- Subjects
- Area Under Curve, Humans, Odds Ratio, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome diagnosis, Severe Fever with Thrombocytopenia Syndrome epidemiology, Thrombocytopenia diagnosis, Thrombocytopenia epidemiology
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging hemorrhagic fever with high mortality. Severe cases progressed rapidly, with deaths occurring within 2 weeks. Therefore, constructing a model to predict disease progression among hospitalized patients plays an important role in clinical practice. The development cohort included 121 patients with SFTS, 25 with severe SFTS, and 96 with mild SFTS. Two of the 64 variables were independent risk factors, including neurological symptoms (odds ratio [OR], 12.915; 95% confidence interval [CI], 3.342-49.916; P < 0.001) and aspartate aminotransferase/alanine aminotransferase levels (OR, 1.891; 95% CI, 1.272-2.813; P = 0.002). The model's area under the curve (AUC) was 0.882 (95% CI: 0.808-0.956). The mean AUC value obtained from the internal validation was 0.883 (95% CI: 0.809-0.957). The AUC in the external validation cohort was 0.873 (95% CI: 0.775-0.972). This model can be used to identify severely ill patients as early as possible with high predictive value, stability, and repeatability. This model can help clinicians with their treatment plans.
- Published
- 2022
- Full Text
- View/download PDF
26. A Patient with Severe Fever with Thrombocytopenia Syndrome (SFTS) Infected from a Sick Dog with SFTS Virus Infection.
- Author
-
Oshima H, Okumura H, Maeda K, Ishijima K, Yoshikawa T, Kurosu T, Fukushi S, Shimojima M, and Saijo M
- Subjects
- Animals, Child, Preschool, Dogs, Humans, Male, Bunyaviridae Infections diagnosis, Bunyaviridae Infections veterinary, Orthobunyavirus, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome diagnosis, Thrombocytopenia, Tick-Borne Diseases, Ticks
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) caused by Dabie bandavirus (formerly SFTS virus, SFTSV), which belongs to the Bandavirus genus (formerly Phlebovirus genus) of the Phenuiviridae family (formerly Bunyaviridae family), is a tick-borne novel bunyavirus infection with high rates of mortality. SFTSV infection was diagnosed virologically in a 4-year-old dog with symptoms of lethargy and anorexia in western Japan in June 2017. The dog's owner, a man in his 40s, had taken care of the sick dog and became sick 10 days after disease onset in the dog, showing symptoms, such as fever, arthralgia, headache, nausea, and vomiting. Total blood cell counts revealed leukocytopenia and thrombocytopenia. He was treated as an outpatient. He had no scars suggesting that he had not been bitten by ticks. He was diagnosed as having SFTS via the detection of IgM and neutralizing antibodies to SFTSV. The patient was directly infected with SFTSV from the SFTSV-infected dog. In conclusion, humans can be at a risk of SFTSV infection through direct contact with sick dogs infected with SFTSV.
- Published
- 2022
- Full Text
- View/download PDF
27. [Infectious causes and management of Japanese spotted fever and severe fever thrombocytopenia syndrome in Ehime prefecture].
- Author
-
Tomita N
- Subjects
- Fever epidemiology, Humans, Communicable Diseases, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Spotted Fever Group Rickettsiosis, Thrombocytopenia diagnosis, Thrombocytopenia epidemiology, Thrombocytopenia etiology, Tick Bites, Tick-Borne Diseases diagnosis, Tick-Borne Diseases epidemiology
- Abstract
Objectives We investigated the infectious causes and management of Japanese spotted fever (JSF) and severe fever thrombocytopenia syndrome (SFTS), which are usually tick-borne infections, at a public health center in Ehime prefecture.Methods The doctor diagnosing JSF and SFTS at the public health center reported the infectious cases using the questionnaire based on the Ehime Epidemiological Surveillance of Infectious Diseases Program.Results There were 91 cases of JSF reported from August 2003, accounting for 56.5% of the whole Ehime prefecture. Since 67.0% of the JSF patients resided near the mountains with citrus cultivations, there were high chances of contact with ticks during farm work or their daily routine even if they did not visit the mountain areas. The distribution of the occupations of the JSF patients was as follows: citrus cultivator, 31.9%; farmer, 14.3%; and retired, 26.4%. The incidence of various clinical symptoms in the JSF patients was as follows: fever and systemic erythema, 100%; tick bite, 73.6%; liver dysfunction, 69.2%; disseminated intravascular coagulation (DIC), 14.3%; and neurological symptoms, 11.0%. The mortality rate was 1.1%. The incidence of DIC, which was considered a severe condition, was significantly low in patients with confirmed tick bites. There were 14 cases of SFTS reported from December 2013, accounting for 42.4% of the whole Ehime prefecture. Notably, 85.7% of the SFTS patients resided in the mountains. Moreover, 85.7% of the SFTS patients were retired. The incidence of various clinical symptoms in the SFTS patients was as follows: fever and marked leucopenia and thrombocytopenia, 100%; tick bite, 57.1%; diarrhea, 71.4%; neurological symptoms, 57.1%; and bleeding tendency, 42.9%. The mortality rate was 35.7%, and the average number of days from onset to death was 11.2 days.Conclusion Since this region is one of the leading citrus producing areas in Ehime prefecture, JSF is considered an occupational disease. It is frequently caused by tick bites while working in the mountain areas of citrus cultivations. Hence, citrus growers should be cautious of tick-borne infections. Recently, the number of JSF cases has been gradually decreasing due to awareness and education of the inhabitants. Currently, SFTS is considered a category IV infection disease, but it can rapidly lead to death after the onset of hemophagocytic syndrome. Therefore, doctors should immediately transfer the patients diagnosed with SFTS to a hospital with an intensive care unit.
- Published
- 2022
- Full Text
- View/download PDF
28. A ten-year assessment of the epidemiological features and fatal risk factors of hospitalised severe fever with thrombocytopenia syndrome in Eastern China.
- Author
-
Zu Z, Hu Y, Zheng X, Chen C, Zhao Y, Jin Y, Lin H, and He N
- Subjects
- China epidemiology, Female, Fever epidemiology, Humans, Male, Middle Aged, Risk Factors, Bunyaviridae Infections, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia epidemiology
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) virus has caused a large number of human infections since discovered in 2009. This study elucidated epidemiological features and fatal risk factors of SFTS cases accumulated up to ten years in Taizhou, a coastal prefecture of Zhejiang Province in Eastern China. A total of 188 hospitalised SFTS cases (including 40 deaths) reported to Taizhou Center for Disease Control and Prevention (CDC) during 2011-2020 were enrolled in the study. In the past decade, the annual incidence of SFTS increased over the years ( P < 0.001) along with an expanding epidemic area, and the case fatality of hospitalised cases has remained high (21.3%). Although most cases occurred in hilly areas, a coastal island had the highest incidence and case fatality. The majority of cases were over the age of 60 years (72.3%), and both incidence and case fatality of SFTS increased with age. Multivariate logistic regression analysis showed that age (OR 7.47, 95% CI 1.32-42.33; P = 0.023), and haemorrhagic manifestations including petechiae (OR 7.76, 95% CI 1.17-51.50; P = 0.034), gingival haemorrhage (OR 5.38, 95% CI 1.25-23.15; P = 0.024) and melena (OR 5.75, 95% CI 1.18-28.07; P = 0.031) were significantly associated with the death of SFTS cases. Five family clusters identified were farmers, among four of which the index patients were female with a history of hypertension. Based on the study, age is a critical risk factor for incidence and case fatality of SFTS. With an increased annual incidence over the last ten years, SFTS remains a public health threat that should not be ignored. Further study is needed to look at the natural foci in the coastal islands.
- Published
- 2022
- Full Text
- View/download PDF
29. Development of a Scoring System to Differentiate Severe Fever with Thrombocytopenia Syndrome from Scrub Typhus.
- Author
-
Sul H, Yun NR, Kim DM, Kim YK, Kim J, Hur J, Jung SI, Ryu SY, Lee JY, Huh K, Kwak YG, Jeong HW, Heo JY, Jung DS, Lee SH, Park SH, Yeom JS, and Lee H
- Subjects
- Humans, Retrospective Studies, Leukopenia diagnosis, Phlebovirus, Scrub Typhus diagnosis, Scrub Typhus epidemiology, Severe Fever with Thrombocytopenia Syndrome diagnosis, Thrombocytopenia diagnosis
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) and scrub typhus are disorders with similar clinical features; therefore, differentiating between them is difficult. We retrospectively collected data from 183 SFTS and 178 scrub typhus patients and validated an existing scoring system to develop a more sensitive, specific, and objective scoring system. We first applied the scoring systems proposed by Kim et al. to differentiate SFTS from scrub typhus. Multivariable logistic regression revealed that altered mental status, leukopenia, prolonged activated partial thromboplastin time (aPTT), and normal C-reactive protein (CRP) level (≤1.0 mg/dL) were significantly associated with SFTS. We changed the normal CRP level from ≤1.0 mg/dL to ≤3.0 mg/dL and replaced altered mental status with the creatine kinase (CK) level. The modified scoring system showed 97% sensitivity and 96% specificity for SFTS (area under the curve (AUC): 0.983) and a higher accuracy than the original scoring system (p = 0.0308). This study’s scoring system had 97% sensitivity and 98% specificity for SFTS (AUC: 0.992) and a higher accuracy than Kim et al.’s original scoring system (p = 0.0308). Our scoring system that incorporated leukopenia, prolonged aPTT, normal CRP level (≤3.0 mg/dL), and elevated CK level (>1000 IU/L) easily differentiated SFTS from scrub typhus in an endemic area.
- Published
- 2022
- Full Text
- View/download PDF
30. Epidemiological and Clinical Characteristics of Severe Fever with Thrombocytopenia Syndrome in Southern Anhui Province, China, 2011-2020.
- Author
-
Wang W, Zhang A, Wu Q, Zhu L, and Yang J
- Subjects
- China epidemiology, Fever diagnosis, Fever epidemiology, Humans, Retrospective Studies, Bunyaviridae Infections diagnosis, Bunyaviridae Infections epidemiology, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia diagnosis, Thrombocytopenia epidemiology
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging hemorrhagic fever, and the causative pathogen, the SFTS virus (SFTSV), was first discovered in China in 2010. In this study, a retrospective analysis of 86 patients that were diagnosed with SFTS from two 5-year periods (2011-2015 and 2016-2020) was performed to explore the changes in epidemiology, clinical characteristics, laboratory parameters, and prognosis between both periods. The results showed that there were significant differences in age, the proportion of farmers, geographical distribution, the incidence of multiple organ dysfunction, the decrease in thrombocyte count, and the elevations of serum AST and lipase levels between the two groups (P < 0.05). Additionally, the case-fatality rate in the 2016-2020 group (16.7%) was higher than that in the 2011-2015 group (6.25%), although the difference was not significant. Our study shows that SFTS is broadly distributed across Anhui Province and the mortality rate is high. May to July was the peak of the epidemic, and farmers constituted a high-risk group. In recent years, thrombocytopenia has become more serious, and multiple organ dysfunction is more common. Clinicians need to strengthen their knowledge of the changing epidemiological and clinical characteristics of this disease.
- Published
- 2022
- Full Text
- View/download PDF
31. L-DOPA, a treatment for Parkinson's disease, and its enantiomer D-DOPA inhibit severe fever with thrombocytopenia syndrome virus infection in vitro.
- Author
-
Ogawa M, Murae M, Gemba R, Irie T, Shimojima M, Saijo M, Noguchi K, and Fukasawa M
- Subjects
- Humans, Levodopa therapeutic use, Bunyaviridae Infections, Hemorrhagic Fevers, Viral, Parkinson Disease drug therapy, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia drug therapy
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is a hemorrhagic fever. Patients mainly develop fever, thrombocytopenia, and leukopenia. A high case fatality rate of 16.2-47% has been reported. Vaccines and antivirals that are effective against SFTS virus (SFTSV) are not yet available in clinical practice. We previously showed that o-dihydroxybenzene is the important chemical core structure for anti-SFTSV activity. In this study, we evaluated the anti-SFTSV efficacy of 3-Hydroxy-L-tyrosine (L-DOPA), a treatment for Parkinson's disease and its enantiomer, 3-hydroxy-D-tyrosine (D-DOPA), both of which have an o-dihydroxybenzene backbone. SFTSV was preincubated with L- or D-DOPA and then inhibition of viral infection as well as viral attachment to host cells were evaluated by viral quantification. Both L- and D-DOPA inhibited SFTSV infection in a dose-dependent manner, mainly by blocking viral attachment to host cells. The half-maximal inhibitory concentration (IC
50 ) of L-DOPA was 4.46-5.09 μM. IC50 of D-DOPA was 4.23-6.72 μM. IC50 of L-DOPA is very close to its maximum blood concentration after oral administration as a therapy for Parkinson's disease. D-DOPA, which IC50 was almost the same as that of L-DOPA, might not cause side effect. Thus, our present study demonstrated that L- and D-DOPA are potentially useful candidates for anti-SFTSV drugs., (Copyright © 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
32. Factors Associated With Severe Fever With Thrombocytopenia Syndrome in Endemic Areas of China.
- Author
-
Jiang X, Wang Y, Zhang X, Pang B, Yao M, Tian X, and Sang S
- Subjects
- China epidemiology, Humans, Temperature, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia epidemiology
- Abstract
Objective: To explore the influence of climatic, environmental and socioeconomic factors on SFTS occurrence in Shandong Province, China., Methods: We used generalized additive model to estimate the association between SFTS cases and climatic factors, environmental factors and socioeconomic factors, including annual average temperature, precipitation, land cover, normalized difference vegetation index, altitude, population density, meat production, milk production, and gross domestic product (GDP)., Results: There were a total of 4,830 cases reported in 100 (70.9%) counties and districts in Shandong Province from 2010 to 2020. The results showed that the annual average temperature, precipitation, forest and grassland coverage rate, altitude and meat production (square root transform) had a reversed "V" relationship with SFTS occurrence, with the inflection points around 12.5-13.0°C in temperature, around 650 mm in precipitation, around 0.3 in forest and grassland coverage rate, around 300 m in altitude, and around 200-300 tons in meat production (square root transform), respectively. SFTS occurrence had a "V" relationship with milk production (square root transform) and GDP (square root transform), with the inflection points around 100-200 tons in milk production (square root transform), and around 150,000-200,000 yuan in GDP (square root transform), respectively., Conclusions: Climatic, environmental, and socioeconomic factors contributed to the heterogeneous distribution of SFTS in Shandong Province, and the influence of these factors on SFTS occurrence was nonlinear., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Jiang, Wang, Zhang, Pang, Yao, Tian and Sang.)
- Published
- 2022
- Full Text
- View/download PDF
33. Clinical Presentation and Mortality of Severe Fever with Thrombocytopenia Syndrome in Japan: A Systematic Review of Case Reports.
- Author
-
Yokomizo K, Tomozane M, Sano C, and Ohta R
- Subjects
- Aged, Animals, Humans, Japan epidemiology, Bunyaviridae Infections, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia diagnosis, Ticks
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is an infection mediated by ticks and has been reported to have a high mortality rate in Japan. At our hospital, we reported three cases of SFTS with relatively positive outcomes. We reviewed reports of SFTS cases in Japan to clarify the current state of the disease in Japan, the treatment provided, and its outcome. The Ichushi Web was searched for literature using the following terms as keywords: "SFTS" or "severe fever with thrombocytopenia syndrome". Overall, 174 cases were collected and reviewed. The mean age of patients was 70.69 years old, and the mortality rate was 35%. The dead group was significantly older ( p < 0.001) than the alive group, had a significantly shorter period from symptom onset to hospital admission, and experienced significantly more hemorrhage-related and neurological symptoms. Further, the most frequently provided treatment methods were adrenocorticosteroids, antibiotics, and conservative treatment. The low recognition rate of SFTS in Japan might lead to a misdiagnosis or delay in diagnosis and treatment, especially in mild to moderate cases. Medical professionals and citizens who live in areas inhabited by ticks need to be informed about SFTS to appropriately diagnose and manage SFTS cases in Japan in the future.
- Published
- 2022
- Full Text
- View/download PDF
34. Acute Myocarditis with Severe Fever and Thrombocytopenia Syndrome.
- Author
-
Okutsu S, Futami M, Arimura T, Ohki K, Hiyoshi T, Sakihara E, Kato Y, Ueda Y, Yano M, Takeshita M, Ishikura H, Suzuki T, Kato S, Miura SI, and Nabeshima S
- Subjects
- Aged, Fever etiology, Humans, Male, Leukopenia, Myocarditis complications, Myocarditis diagnosis, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia complications, Thrombocytopenia diagnosis
- Abstract
A 67-year-old man, hospitalized with fever and pancytopenia, experienced cardiogenic shock on the 3rd day of hospitalization. He complained of chest pain and exhibited cardiac dysfunction, upregulated serum troponin levels, and an ST elevation on electrocardiogram. Severe fever with thrombocytopenia syndrome (SFTS) was suspected based on the symptom course after a tick bite and was definitively diagnosed using the serum polymerase chain reaction (PCR) test. An endomyocardial biopsy performed in the convalescent phase revealed a sign of myocardial inflammation with increases in CD3- and CD68-positive cells. We herein report the first case of acute myocarditis complicated with SFTS.
- Published
- 2022
- Full Text
- View/download PDF
35. [A review on the epidemiology of severe fever with thrombocytopenia syndrome].
- Author
-
Li JC, Wang YN, Zhao J, Li H, and Liu W
- Subjects
- China epidemiology, Fever, Humans, Bunyaviridae Infections epidemiology, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia epidemiology
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne infectious disease discovered in the 21
st century. This disease has been reported in several Asian countries, including China, Japan, South Korea, Vietnam, and Myanmar. Until 2019, SFTS cases have been reported in 25 provinces in China, and most of them were rural residents from mountains and hilly regions. Most SFTS cases were sporadic but geographically concentrated, mainly in Henan, Shandong, Anhui, Hubei, Liaoning, Zhejiang, and Jiangsu provinces. SFTSV infection was transmitted predominantly by a tick bite and potentially through close contact with the patient's blood or body fluids. Fever, gastrointestinal symptoms, thrombocytopenia, and leukopenia were common initial manifestations, and multiple organ failure or even death could occur in severe cases. The reported cases of SFTS have been gradually increasing, and the case fatality rate has remained at a high level, posing a severe threat to public health in China. This paper reviewed the epidemiological features, risk factors for disease transmission, and the clinical characteristics of SFTS to gain further knowledge of the disease, guide the prevention and management, and help reduce the case fatality rate.- Published
- 2021
- Full Text
- View/download PDF
36. Epidemiology and Ecology of Severe Fever With Thrombocytopenia Syndrome in China, 2010‒2018.
- Author
-
Miao D, Liu MJ, Wang YX, Ren X, Lu QB, Zhao GP, Dai K, Li XL, Li H, Zhang XA, Shi WQ, Wang LP, Yang Y, Fang LQ, and Liu W
- Subjects
- China epidemiology, Fever epidemiology, Humans, Middle Aged, Bunyaviridae Infections epidemiology, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia
- Abstract
Background: The growing epidemics of severe fever with thrombocytopenia syndrome (SFTS), an emerging tick-borne disease in East Asia, and its high case fatality rate have raised serious public health concerns., Methods: Surveillance data on laboratory-confirmed SFTS cases in China were collected. The spatiotemporal dynamics and epidemiological features were explored. The socioeconomic and environmental drivers were identified for SFTS diffusion using survival analysis and for SFTS persistence using a two-stage generalized boosted regression tree model., Results: During 2010‒2018, a total of 7721 laboratory-confirmed SFTS cases were reported in China, with an overall case fatality rate (CFR) of 10.5%. The average annual incidence increased >20 times and endemic areas expanded from 27 to 1574 townships, whereas the CFR declined from 19% to 10% during this period. Four geographical clusters-the Changbai Mountain area, the Jiaodong Peninsula, the Taishan Mountain area, and the Huaiyangshan Mountain area-were identified. Diffusion and persistence of the disease were both driven by elevation, high coverages of woods, crops, and shrubs, and the vicinity of habitats of migratory birds but had different meteorological drivers. Residents ≥60 years old in rural areas with crop fields and tea farms were at increased risk to SFTS., Conclusions: Surveillance of SFTS and intervention programs need to be targeted at areas ecologically suitability for vector ticks and in the vicinity of migratory birds to curb the growing epidemic., (© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2021
- Full Text
- View/download PDF
37. Factors associated with spatial distribution of severe fever with thrombocytopenia syndrome.
- Author
-
Sun JM, Wu HX, Lu L, Liu Y, Mao ZY, Ren JP, Yao WW, Qu HH, and Liu QY
- Subjects
- Animals, China epidemiology, Meteorological Concepts, Bunyaviridae Infections, Phlebovirus, Thrombocytopenia
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) was firstly identified in mainland China in 2009 and the geographic distribution has expanded in recent years. In this study, we constructed ecological niche models (ENM) of SFTS with meteorological factors, environmental factor, and density of domestic animals using MaxEnt. We found four significant associated factors including altitude, yearly average temperature, yearly accumulated precipitation, and yearly average relative humidity which accounted for 94.1% percent contribution. SFTS occurrence probability was high when altitude was between -100 m and 100 m, and the probability was nearly 0 when altitude was beyond 3000 m. Response curves of SFTS to the yearly average temperature, yearly accumulated precipitation, and yearly average relative humidity were all reversed V-shape. SFTS occurrence probability was high where the yearly average temperature, yearly accumulated precipitation, and yearly relative humidity were 12.5-17.5 °C, 700-2250 mm and 63-82%, respectively. ENMs predicted that the potential high-risk areas were mainly distributed in eastern areas and central areas of China. But there were some predicted potential high-risk areas where no SFTS case was reported up to date. More researches should be done to make clear whether SFTS case had occurred in these areas., Competing Interests: Declaration of competing interest The authors have declared that no competing interests exist., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
38. Mapping the global potential transmission hotspots for severe fever with thrombocytopenia syndrome by machine learning methods.
- Author
-
Miao D, Dai K, Zhao GP, Li XL, Shi WQ, Zhang JS, Yang Y, Liu W, and Fang LQ
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Animals, Bunyaviridae Infections epidemiology, Child, Child, Preschool, Communicable Diseases, Emerging epidemiology, Communicable Diseases, Emerging transmission, Communicable Diseases, Emerging virology, Female, Humans, Male, Middle Aged, Phlebovirus pathogenicity, Temperature, Thrombocytopenia virology, Young Adult, Bunyaviridae Infections transmission, Disease Vectors, Global Health statistics & numerical data, Ixodidae virology, Machine Learning, Thrombocytopenia epidemiology
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with increasing spread. Currently SFTS transmission has expanded beyond Asian countries, however, with definitive global extents and risk patterns remained obscure. Here we established an exhaustive database that included globally reported locations of human SFTS cases and the competent vector, Haemaphysalis longicornis ( H. longicornis ), as well as the explanatory environmental variables, based on which, the potential geographic range of H. longicornis and risk areas for SFTS were mapped by applying two machine learning methods. Ten predictors were identified contributing to global distribution for H. longicornis with relative contribution ≥1%. Outside contemporary known distribution, we predict high receptivity to H. longicornis across two continents, including northeastern USA, New Zealand, parts of Australia, and several Pacific islands. Eight key drivers of SFTS cases occurrence were identified, including elevation, predicted probability of H. longicornis presence, two temperature-related factors, two precipitation-related factors, the richness of mammals and percentage coverage of water bodies. The globally model-predicted risk map of human SFTS occurrence was created and validated effective for discriminating the actual affected and unaffected areas (median predictive probability 0.74 vs. 0.04, P < 0.001) in three countries with reported cases outside China. The high-risk areas (probability ≥50%) were predicted mainly in east-central China, most parts of the Korean peninsula and southern Japan, and northern New Zealand. Our findings highlight areas where an intensive vigilance for potential SFTS spread or invasion events should be advocated, owing to their high receptibility to H. longicornis distribution.
- Published
- 2020
- Full Text
- View/download PDF
39. Predictive risk score model for severe fever with thrombocytopenia syndrome mortality based on qSOFA and SIRS scoring system.
- Author
-
Wang L, Zou Z, Ding K, and Hou C
- Subjects
- Age Factors, Aged, Area Under Curve, Aspartate Aminotransferases blood, Female, Hospital Mortality, Humans, Male, Middle Aged, Phlebotomus Fever blood, Prognosis, Retrospective Studies, Reverse Transcriptase Polymerase Chain Reaction, Risk Factors, Sepsis mortality, Syndrome, Organ Dysfunction Scores, Phlebotomus Fever complications, Phlebotomus Fever mortality, Phlebovirus genetics, Thrombocytopenia complications, Thrombocytopenia mortality
- Abstract
Background: Severe fever with thrombocytopenia syndrome (SFTS) is a severe systemic virus infectious disease usually having multi-organ dysfunction which resembles sepsis., Methods: Data of 321 patients with laboratory-confirmed SFTS from May 2013 to July 2017 were retrospectively analyzed. Demographic and clinical characteristics, calculated quick sequential organ failure assessment (qSOFA) score and systemic inflammatory response syndrome (SIRS) criteria for survivors and nonsurvivors were compared. Independent risk factors associated with in-hospital mortality were obtained using multivariable logistic regression analysis. Risk score models containing different risk factors for mortality in stratified patients were established whose predictive values were evaluated using the area under ROC curve (AUC)., Results: Of 321 patients, 87 died (27.1%). Age (p < 0.001) and percentage numbers of patients with qSOFA≥2 and SIRS≥2 (p < 0.0001) were profoundly greater in nonsurvivors than in survivors. Age, qSOFA score, SIRS score and aspartate aminotransferase (AST) were independent risk factors for mortality for all patients. qSOFA score was the only common risk factor in all patients, those age ≥ 60 years and those enrolled in the intensive care unit (ICU). A risk score model containing all these risk factors (Model1) has high predictive value for in-hospital mortality in these three groups with AUCs (95% CI): 0.919 (0.883-0.946), 0.929 (0.862-0.944) and 0.815 (0.710-0.894), respectively. A model only including age and qSOFA also has high predictive value for mortality in these groups with AUCs (95% CI): 0.872 (0.830-0.906), 0.885(0.801-0.900) and 0.865 (0.767-0.932), respectively., Conclusions: Risk models containing qSOFA have high predictive validity for SFTS mortality.
- Published
- 2020
- Full Text
- View/download PDF
40. High Levels of Circulating Cell-free DNA Are Associated With a Poor Prognosis in Patients With Severe Fever With Thrombocytopenia Syndrome.
- Author
-
Zhang Y, Song R, Shen Y, Zhao Y, Zhao Z, Fan T, Yang X, Wang L, Zhang W, Chen C, Tian D, Wang Y, Wen J, Ge Z, Yu X, Liu L, Feng Y, Duan J, Ma Y, Li X, Zeng H, Chen Z, and Zhu L
- Subjects
- Humans, Prognosis, Prospective Studies, Cell-Free Nucleic Acids, Phlebovirus genetics, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia
- Abstract
Background: The extensive geographical distribution and high mortality rate of severe fever with thrombocytopenia syndrome (SFTS) have made it an important threat to public health. Neutrophil extracellular traps (NETs) can be activated by a variety of pathogens and are associated with thrombocytopenia in viral infections. We aimed to identify NET production and its predictive value for disease progression and prognosis in patients with SFTS., Methods: A prospective study was performed with a multicenter cohort of patients with SFTS (n = 112) to quantify serum NET levels. Three markers of NETs-namely, cell-free DNA (cfDNA), myeloperoxidase-DNA complexes, and lactoferrin-DNA complexes-were measured with PicoGreen double-stranded DNA assays and enzyme-linked immunosorbent assays. Receiver operating characteristic curves and multivariate regression analyses were performed to calculate the predictive value of cfDNA levels., Results: SFTS was characterized by pronounced NET formation. The serum levels of NETs changed dynamically during disease progression, with an inverse pattern of the trends of platelet and neutrophil levels. High cfDNA levels were strongly associated with multiple pathological processes, including coagulopathy, myocardial damage, liver dysfunction, and the development of encephalopathy. A high level of cfDNA (>711.7 ng/mL) at the time of the initial diagnosis predicted severe illness in patients with SFTS (odds ratio, 8.285 [95% confidence interval, 2.049-33.503]; P = .003)., Conclusions: This study has a high degree of clinical impact for identification of cfDNA as a useful predictive biomarker of clinical outcomes of SFTS., (© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
41. Invasive Pulmonary Aspergillosis in Patients With Severe Fever With Thrombocytopenia Syndrome.
- Author
-
Bae S, Hwang HJ, Kim MY, Kim MJ, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, and Kim SH
- Subjects
- Antifungal Agents therapeutic use, Fever drug therapy, Humans, Intensive Care Units, Retrospective Studies, Invasive Pulmonary Aspergillosis complications, Invasive Pulmonary Aspergillosis diagnosis, Invasive Pulmonary Aspergillosis drug therapy, Severe Fever with Thrombocytopenia Syndrome, Thrombocytopenia complications
- Abstract
Sixteen of 45 patients with severe fever with thrombocytopenia (36%) were admitted to an intensive care unit; 9 (56%) developed invasive pulmonary aspergillosis (IPA) within a median of 8 days (range, 2-11). Mortality was higher in the IPA vs non-IPA patients and in those without vs with antifungal therapy., (© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
42. [Emerging and Re-emerging Virus Infections in Japan: Dengue Fever, Zika Virus Disease, and SFTS].
- Author
-
Saijo M
- Subjects
- Disease Outbreaks, Humans, Japan epidemiology, Syndrome, Communicable Diseases, Emerging epidemiology, Dengue epidemiology, Fever epidemiology, Thrombocytopenia epidemiology, Zika Virus Infection epidemiology
- Abstract
A sporadic but autochthonous dengue fever outbreak occurred in Tokyo in 2014, although the dengue virus is not in general circulation in Japan. Another lethal infectious disease, known as severe fever with thrombocytopenia syndrome (SFTS), was discovered to be endemic to Japan in January 2013. More than 400 patients with SFTS have been reported so far. The fatality rate of SFTS is approximately 30%. Also in 2014, a large outbreak of mosquito-borne Zika virus infections occurred in the South and Central parts of the American continent. Transplacental infection of a fetus with Zika virus occurs when pregnant women are infected. We cannot escape the risk of being infected with these viruses. Thus, preparedness for these emerging and reemerging virus infections is required.
- Published
- 2020
- Full Text
- View/download PDF
43. Dyspnea and Wheezing as the Earliest Manifestations of Severe Fever with Thrombocytopenia Syndrome: The First Case Report.
- Author
-
Yamashita S, Katsuki NE, Tago M, and Yamashita SI
- Subjects
- Bunyaviridae Infections diagnosis, Diarrhea etiology, Female, Humans, Lung diagnostic imaging, Middle Aged, Phlebovirus genetics, Pulmonary Disease, Chronic Obstructive complications, Pulmonary Disease, Chronic Obstructive diagnosis, Pulmonary Edema diagnostic imaging, Radiography, Thoracic, Tomography, X-Ray Computed, Bunyaviridae Infections complications, Dyspnea etiology, Pulmonary Edema etiology, Respiratory Sounds etiology, Thrombocytopenia etiology
- Abstract
A 64-year-old Japanese woman developed fatigue, dyspnea, and wheezing in July. Although she had been undergoing treatment for chronic obstructive pulmonary disease for six days, she was transferred to our hospital with delirium and diarrhea. On admission, she had an eschar of 3 mm in diameter on her anterior chest. Polymerase chain reaction of her blood and eschar specimens led to the diagnosis of severe fever with thrombocytopenia syndrome. Chest computed tomography showed ground-glass opacities, suggesting noncardiogenic pulmonary edema or viral pneumonia. This is the first case report of severe fever with thrombocytopenia syndrome beginning with dyspnea and wheezing.
- Published
- 2019
- Full Text
- View/download PDF
44. Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome.
- Author
-
Yoo JR, Kim SH, Kim YR, Lee KH, Oh WS, and Heo ST
- Subjects
- Aged, Bunyaviridae Infections blood, Bunyaviridae Infections diagnosis, Bunyaviridae Infections virology, Disease Progression, Female, Fever blood, Fever diagnosis, Fever virology, Humans, Male, Middle Aged, Retrospective Studies, Severity of Illness Index, Thrombocytopenia blood, Thrombocytopenia diagnosis, Thrombocytopenia virology, Treatment Outcome, Viral Load, Bunyaviridae Infections therapy, Fever therapy, Phlebovirus pathogenicity, Plasma Exchange, Thrombocytopenia therapy
- Abstract
Background/aims: Severe fever with thrombocytopenia syndrome (SFTS) is a viral hemorrhagic fever with a high fatality rate. However, effective treatments for SFTS cases not responded to supportive therapy have not been established. Herein, we introduced the therapeutic plasma exchange (TPE) in SFTS patients in a tertiary hospital between 2013 and 2015., Methods: TPE was performed in patients with rapidly progressing SFTS. Clinical, laboratory, and virological parameters were compared before and after TPE., Results: Among 27 confirmed SFTS patients, two patients were treated with TPE and ribavirin combination in May 2013, then, 14 patients with rapidly progressing SFTS patients were treated with only TPE from June 2013 to September 2015: their median age was 58 years (interquartile range, 50 to 70) and eight (57.1%) were male. Body temperature, pressure-adjusted heart rate, white blood cell and platelet counts, coagulation profile, serum creatinine, and multiple organ dysfunction score improved immediately after TPE. In addition, the mean cyclic threshold value of real-time reverse transcriptase polymerase chain reaction for SFTS virus after TPE (mean ± standard deviation, 31.3 ± 2.9) was significantly higher than that before TPE (26.5 ± 2.9; p < 0.001), indicating that serum viral loads decreased after TPE. Finally, 13 of 14 TPE-treated patients (92.8%) recovered from rapidly progressing SFTS without sequelae., Conclusion: SFTS patients treated with TPE showed improvements in clinical, laboratory, and virological parameters. These results suggest that TPE would be a therapeutic modality as rescue therapy in patients with rapidly progressing SFTS.
- Published
- 2019
- Full Text
- View/download PDF
45. Spatial epidemiological determinants of severe fever with thrombocytopenia syndrome in Miyazaki, Japan: a GWLR modeling study.
- Author
-
Yasuo K and Nishiura H
- Subjects
- Animals, Area Under Curve, Humans, Japan epidemiology, Logistic Models, Odds Ratio, ROC Curve, Thrombocytopenia epidemiology, Fever etiology, Models, Theoretical, Thrombocytopenia diagnosis
- Abstract
Background: Cases of severe fever with thrombocytopenia syndrome (SFTS) have increasingly been observed in Miyazaki, southwest Japan. It is critical to identify and elucidate the risk factors of infection at community level. In the present study, we aimed to identify areas with a high risk of SFTS virus infection using a geospatial dataset of SFTS cases in Miyazaki., Methods: Using 10 × 10-km mesh data and a geographically weighted logistic regression (GWLR) model, we examined the statistical associations between environmental variables and spatial variation in the risk of SFTS. We collected geospatial and population census data as well as forest and agriculture mesh information. Altitude and farmland were selected as two specific variables for predicting the presence of SFTS cases in a given mesh area., Results: Using GWLR, the area under the receiver operating characteristic curve (AUC) was estimated at 73.9%, outperforming the classical logistic regression model (72.4%). The sensitivity and specificity of the GWLR model were estimated at 90.9 and 58.7%, respectively. We identified altitude (odds ratio (OR) = 0.996, 95% confidence interval (CI): 0.994-0.999 per one-meter elevation) and farmland (OR = 0.999, 95% CI: 0.998-1.000 per % increase) as useful negative predictors of SFTS cases in Miyazaki., Conclusions: Our study findings revealed that the risk of SFTS is high in geographic areas where farmland area begins to diminish and at mid-level altitudes. Our findings can help to improve the efficiency of ecological and animal surveillance in high-risk areas. Using finer geographic resolution, such surveillance can help raise awareness among local residents in areas with a high risk of SFTS.
- Published
- 2019
- Full Text
- View/download PDF
46. Transient Appearance of Plasmablasts in the Peripheral Blood of Japanese Patients With Severe Fever With Thrombocytopenia Syndrome.
- Author
-
Takahashi T, Suzuki T, Hiroshige S, Nouno S, Matsumura T, Tominaga T, Yujiri T, Katano H, Sato Y, and Hasegawa H
- Subjects
- Aged, Aged, 80 and over, Antigens, CD immunology, Asian People, Female, Fever immunology, Flow Cytometry methods, Humans, Japan, Male, Middle Aged, Phenotype, Lymphocytes immunology, Plasma Cells immunology, Thrombocytopenia immunology
- Abstract
Atypical lymphocytes in the peripheral blood in patients with severe fever with thrombocytopenia syndrome (SFTS) have not been well examined. In this study, we analyzed counts and characteristics of atypical lymphocytes in 7 patients with SFTS. Atypical lymphocytes resembled plasma cells morphologically and appeared in the peripheral blood of all patients 4-8 days after onset of disease. Among these lymphocytes flow cytometry showed a CD19+CD38+CD138-/+ phenotype, and immunohistochemical staining revealed a CD79a+CD38+CD138-/+CD27+ phenotype. From our observations, atypical lymphocytes transiently that appeared in the peripheral blood during the acute phase of SFTS were considered to be plasmablasts., (© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.)
- Published
- 2019
- Full Text
- View/download PDF
47. Cutaneous histopathology of the tick-bite region in severe fever with thrombocytopenia syndrome.
- Author
-
Sato T, Nishida H, Goto M, Sho Y, Yamate T, Daa T, Yokoyama S, Kurosawa K, Matsunari O, Sakamoto T, Matsumoto H, Suzuki T, Hasegawa H, Takeo N, and Hatano Y
- Subjects
- Aged, Biopsy, Disseminated Intravascular Coagulation blood, Disseminated Intravascular Coagulation diagnosis, Fatal Outcome, Female, Humans, Phlebotomus Fever blood, Phlebotomus Fever diagnosis, Phlebovirus genetics, RNA, Viral isolation & purification, Skin pathology, Skin virology, Syndrome, Thrombocytopenia blood, Thrombocytopenia diagnosis, Tick Bites blood, Tick Bites complications, Tick Bites virology, Disseminated Intravascular Coagulation virology, Phlebotomus Fever virology, Phlebovirus isolation & purification, Thrombocytopenia virology, Tick Bites pathology
- Abstract
A case of severe fever with thrombocytopenia syndrome (SFTS) in which a skin biopsy from the tick-bite region was analyzed is reported. The patient was a 72-year-old woman who developed fever and thrombocytopenia after a tick bite. SFTS was diagnosed from polymerase chain reaction (PCR) analysis of a blood sample. Histopathological analysis of a skin biopsy specimen from the tick-bite region showed CD20-positive perivascular and interstitial immunoblastic cells, which were positive to anti-SFTS virus (SFTSV) nucleoprotein antibody. In addition, SFTSV RNA was detected by real-time PCR from this biopsy specimen. Moreover, hemophagocytosis was also found in the tick-bite region. To the best of our knowledge, this is the first report to analyze the details of the tick-bite region of skin in SFTS, and the first to detect virus-infected cells in the skin. The present findings may help elucidate the mechanisms of entry of SFTSV., (© 2019 Japanese Dermatological Association.)
- Published
- 2019
- Full Text
- View/download PDF
48. Endemic Severe Fever with Thrombocytopenia Syndrome, Vietnam.
- Author
-
Tran XC, Yun Y, Van An L, Kim SH, Thao NTP, Man PKC, Yoo JR, Heo ST, Cho NH, and Lee KH
- Subjects
- Adult, Bunyaviridae Infections diagnosis, Female, Genes, Viral, Humans, Male, Phylogeny, Public Health Surveillance, Symptom Assessment, Thrombocytopenia diagnosis, Tick-Borne Diseases diagnosis, Vietnam epidemiology, Bunyaviridae Infections epidemiology, Bunyaviridae Infections virology, Phlebovirus classification, Phlebovirus genetics, Phlebovirus isolation & purification, Thrombocytopenia epidemiology, Thrombocytopenia virology, Tick-Borne Diseases epidemiology, Tick-Borne Diseases virology
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS), a tickborne viral disease, has been identified in China, South Korea, and Japan since 2009. We found retrospective evidence of SFTS virus (SFTSV) infection in Vietnam, which suggests that SFTSV infections also occur in Vietnam, where the virus has not been known to be endemic.
- Published
- 2019
- Full Text
- View/download PDF
49. Fulminant myocarditis associated with severe fever with thrombocytopenia syndrome: a case report.
- Author
-
Miyamoto S, Ito T, Terada S, Eguchi T, Furubeppu H, Kawamura H, Yasuda T, and Kakihana Y
- Subjects
- Communicable Diseases, Emerging complications, Echocardiography, Electrocardiography, Female, Fever etiology, Humans, Leukopenia, Middle Aged, Myocarditis complications, Myocarditis diagnosis, Real-Time Polymerase Chain Reaction, Syndrome, Bunyaviridae Infections complications, Hemorrhagic Fevers, Viral complications, Myocarditis etiology, Thrombocytopenia complications
- Abstract
Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral infectious disease with high mortality. It causes multiple organ dysfunction; however, myocarditis has never been reported as a complication with SFTS., Case Presentation: A 62-year-old previously healthy woman developed fever, fatigue, diarrhea, and a mild consciousness disorder. She visited a local clinic, and laboratory data showed leukocytopenia, thrombocytopenia, and elevation of the aspartate aminotransferase level. She was transferred to Kagoshima University Hospital and diagnosed as having SFTS by real-time reverse transcription polymerase chain reaction. Subsequently, her blood pressure gradually decreased despite fluid resuscitation and vasopressor administration. Based on elevated toroponin I levels in serum, a transient diffuse left ventricular hypokinesis and wall thickening in echocardiography, diffuse ST elevation in electrocardiography, and exclusion of other heart diseases, she was diagnosed as having fulminant myocarditis. After hemodynamic support with inotropic agents, she recovered near normal cardiac function. She was discharged to home on day 28., Conclusions: We report the first case of fulminant myocarditis associated with SFTS.
- Published
- 2019
- Full Text
- View/download PDF
50. Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy.
- Author
-
Saijo M
- Subjects
- Aged, 80 and over, Animals, Bunyaviridae Infections epidemiology, Bunyaviridae Infections pathology, Bunyaviridae Infections prevention & control, China epidemiology, Female, Humans, Japan epidemiology, Male, Mice, Mice, Knockout, Middle Aged, Mortality, Republic of Korea epidemiology, Syndrome, Thrombocytopenia epidemiology, Thrombocytopenia pathology, Thrombocytopenia prevention & control, Amides therapeutic use, Antiviral Agents therapeutic use, Bunyaviridae Infections drug therapy, Phlebovirus pathogenicity, Pyrazines therapeutic use, Thrombocytopenia drug therapy
- Abstract
Severe fever with thrombocytopenia syndrome (SFTS) caused by SFTS virus (SFTSV), a novel phlebovirus, was reported to be endemic to central and northeastern PR China and was also to be endemic to South Korea and western Japan. SFTS is an emerging viral infection, which should be categorized as a viral hemorrhagic fever disease as Crimean-Congo hemorrhagic fever (CCHF) is caused by CCHF virus. SFTS is a tick-borne viral infection. SFTSV is maintained between several species of ticks and wild and domestic animals in nature. Patients with SFTS show symptoms of fever, general fatigue, and gastrointestinal symptoms such as bloody diarrhea. The severely ill SFTS patients usually show gastrointestinal hemorrhage and deteriorated consciousness. The case fatality rate of SFTS ranges from 5 to 40%. Pathological studies on SFTS have revealed that the mechanisms behind the high case fatality rate are virus infection-related hemophagocytic syndrome associated with cytokine storm, coagulopathy due to disseminated intravascular coagulation causing bleeding tendency, and multi-organ failure. Favipiravir was reported to show efficacy in the prevention and treatment of SFTSV infections in an animal model. A clinical study to evaluate the efficacy of favipiravir in the treatment of SFTS patients has been initiated in Japan. SFTSV is circulating in nature in PR China, Korea, and Japan, indicating that we cannot escape from the risk being infected with SFTSV. The development of specific therapy and preventive measures is a pressing issue requiring resolution to reduce the morbidity and mortality of SFTS patients., (Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.